<DOC>
	<DOCNO>NCT01306422</DOCNO>
	<brief_summary>The objective clinical study ass safety , tolerability , efficacy ( effect appetite score , food intake ) plasma kinetics Hoodia gordonii purify extract ( H.g.PE ) , consume twice-daily 2 15-days .</brief_summary>
	<brief_title>Safety , Tolerability , Kinetics Efficacy Study Hoodia Gordonii Purified Extract ( PYM50717 )</brief_title>
	<detailed_description>A two stage randomize , double-blind , placebo-controlled study evaluate safety , tolerability , kinetics efficacy twice-daily repeat intake formulate Hoodia gordonii purify extract ( H.g.PE ) ( PYM50717 ) administer twice daily 2 15 day healthy , overweight female age 18 50 year body fat 25-45 % . Stage 1 ( pilot ) : Placebo control , double blind comparison ass effect time product administration ( i.e . breakfast lunch v breakfast dinner ) . Stage 2 ( main study ) : Placebo control double blind comparison product administer breakfast dinner . A total 64 subject include study ; stage 1 : n=15 , stage 2 : n=49 . Treatment group stage 2 matched percentage body fat . Stage 1 : - H.g.PE formulate product ( 1110 mg ) , twice-daily two day , 65 minute breakfast lunch ( n = 4 ) . - Placebo product , twice-daily two day , 65 minute breakfast lunch ( n = 3 ) . - H.g.PE formulate product ( 1110 mg ) , twice-daily two day , 65 minute breakfast dinner ( n = 5 ) . - Placebo product , twice-daily two day , 65 minute breakfast dinner ( n = 3 ) . Stage 2 : - H.g.PE formulate product ( 1110 mg ) , twice daily ( n=25 ) 15 day - Placebo product , twice daily ( n=24 ) , 15 day</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<criteria>Healthy female age 18 50 year . Body fat 25 % 45 % assessed Dual Energy Xray absorptiometry ( DEXA ) scan Screening . Stable body weight least two month prior Screening ( weight loss gain &gt; 5 % consider unstable ) . Regularly consume least three meal per day , include breakfast . Agreed abstain strenuous exercise throughout entire study . Subjects pregnant , lactate willing use two contraceptive ( include least one barrier contraceptive ) start least 14 day study product administration ( Day 1 ) least 30 day follow study product administration ( except subject surgically sterilize one year postmenopausal ) . Subjects take prescription counter medication ( exception hormonal contraceptive ) ( include supplement , especially related weight management [ eg , ephedrine , caffeine , synephrine ] ) within one week prior Visit 2 ( Day 1 ) , antibiotic &lt; 3 month prior Day 1 , plan course study . Smokers , exsmokers smoke cigarette past six month prior study product administration and/or use another form nicotinecontaining product . Fasting blood glucose &gt; 7 mmol/L ( 126 mg/dL ) Screening . Psychiatric disorder could interfere subject 's compliance requirement protocol , discretion Investigator . Used plan use medically prescribe diet weightloss diet make attempt control diet Screening entire study . Strenuous exercise &gt; 5 hour per week ( eg , sport ) . Restrained eat behavior determine score â‰¥16 Revised Restraint Scale low score Food Action Rating Scale</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>hoodia gordonii</keyword>
	<keyword>energy intake</keyword>
	<keyword>food intake</keyword>
	<keyword>efficacy</keyword>
	<keyword>body weight</keyword>
	<keyword>functional food</keyword>
	<keyword>plant extract</keyword>
	<keyword>safety</keyword>
	<keyword>steroid glycoside</keyword>
	<keyword>tolerability</keyword>
</DOC>